The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Cooperation between integrin ανβ3 and VEGFR2 in angiogenesis
Open accessAbstract
The cross-talk between receptor tyrosine kinases and integrin receptors are known to be crucial for a number of cellular functions. On endothelial cells, an interaction between integrin αvβ3 and VEGFR2 seems to be particularly important process during vascularization. Importantly, the functional association between VEGFR2 and integrin αvβ3 is of reciprocal nature since each receptor is able to promote activation of its counterpart. This mutually beneficial relationship regulates a number of cellular activities involved in angiogenesis, including endothelial cell migration, survival and tube formation, and hematopoietic cell functions within vasculature. This article discusses several possible mechanisms reported by different labs which mediate formation of the complex between VEGFR-2 and αvβ3 on endothelial cells. The pathological consequences and regulatory events involved in this receptor cross-talk are also presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., & Iruela-Arispe, M. L. (2007) · Cell · doi:10.1016/j.cell.2007.06.054 · Cited by 1,046
Ingber, D. E., & Folkman, J. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.317 · Cited by 868
Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., & Cheresh, D. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80221-x · Cited by 813
Src family kinases are required for integrin but not PDGFR signal transduction
Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., & Soriano, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2459 · Cited by 731
Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts
McHugh, K. P., Hodivala-Dilke, K., Zheng, M.-H., Namba, N., Lam, J., Novack, D., Feng, X., Ross, F. P., Hynes, R. O., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8905 · Cited by 727
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
A reevaluation of integrins as regulators of angiogenesis
Hynes, R. O. (2002) · Nature Medicine · doi:10.1038/nm0902-918 · Cited by 548
Schneller, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5600 · Cited by 492
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Stockmann, C., Doedens, A., Weidemann, A., Zhang, N., Takeda, N., Greenberg, J. I., Cheresh, D. A., & Johnson, R. S. (2008) · Nature · doi:10.1038/nature07445 · Cited by 471
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
Chen, J., Somanath, P. R., Razorenova, O., Chen, W. S., Hay, N., Bornstein, P., & Byzova, T. V. (2005) · Nature Medicine · doi:10.1038/nm1307 · Cited by 456
Self-citationTumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis
Maeshima, Y., Sudhakar, A., Lively, J. C., Ueki, K., Kharbanda, S., Kahn, C. R., Sonenberg, N., Hynes, R. O., & Kalluri, R. (2002) · Science · doi:10.1126/science.1065298 · Cited by 438
Ginsberg, M. H., Partridge, A., & Shattil, S. J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.010 · Cited by 415
Structure and mechanics of integrin-based cell adhesion
Arnaout, M. A., Goodman, S. L., & Xiong, J.-P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.08.002 · Cited by 403
Neuropilins: structure, function and role in disease
Pellet-Many, C., Frankel, P., Jia, H., & Zachary, I. (2008) · Biochemical Journal · doi:10.1042/bj20071639 · Cited by 395
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Simo, R., Carrasco, E., Garcia-Ramirez, M., & Hernandez, C. (2006) · Current Diabetes Reviews · doi:10.2174/157339906775473671 · Cited by 364
Association of insulin receptor substrate-1 with integrins
Vuori, K., & Ruoslahti, E. (1994) · Science · doi:10.1126/science.7527156 · Cited by 360
Jones, P. L., Crack, J., & Rabinovitch, M. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.279 · Cited by 350
Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis
Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., & Byzova, T. V. (2007) · Circulation Research · doi:10.1161/circresaha.107.155655 · Cited by 298
Self-citationStupack, D. G., & Cheresh, D. A. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)64009-9 · Cited by 295
Borges, E., Jan, Y., & Ruoslahti, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007040200 · Cited by 293
Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., Patel, Y., Suda, Y., Humphries, M. J., & Sobel, M. (2006) · Circulation Research · doi:10.1161/01.res.0000246849.17887.66 · Cited by 293
Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Kumar, C. (2003) · Current Drug Targets · doi:10.2174/1389450033346830 · Cited by 280
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
Andreoli, C. M., & Miller, J. W. (2007) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e3282f0ca54 · Cited by 274
VEGF receptor protein–tyrosine kinases: Structure and regulation
Roskoski, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.121 · Cited by 269
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src−/− mutant mice
Schwartzberg, P. L., Xing, L., Hoffmann, O., Lowell, C. A., Garrett, L., Boyce, B. F., & Varmus, H. E. (1997) · Genes & Development · doi:10.1101/gad.11.21.2835 · Cited by 268
β8 integrins are required for vascular morphogenesis in mouse embryos
Zhu, J., Motejlek, K., Wang, D., Zang, K., Schmidt, A., & Reichardt, L. F. (2002) · Development · doi:10.1242/dev.129.12.2891 · Cited by 267
Leu, S.-J., Lam, S. C.-T., & Lau, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209288200 · Cited by 247
Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism
Cai, W., & Chen, X. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778226530 · Cited by 235
Doerr, M. E., & Jones, J. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2443 · Cited by 216
Integrin signaling is critical for pathological angiogenesis
Mahabeleshwar, G. H., Feng, W., Phillips, D. R., & Byzova, T. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060807 · Cited by 206
Self-citationNeuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting
Pan, Q., Chathery, Y., Wu, Y., Rathore, N., Tong, R. K., Peale, F., Bagri, A., Tessier-Lavigne, M., Koch, A. W., & Watts, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703554200 · Cited by 204
α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines
Falcioni, R., Antonini, A., Nisticò, P., Stefano, S. D., Crescenzi, M., Natali, P. G., & Sacchi, A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3695 · Cited by 202
Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Cai, W., Niu, G., & Chen, X. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404308 · Cited by 178
Vascular Development of the Brain Requires β8 Integrin Expression in the Neuroepithelium
Proctor, J. M., Zang, K., Wang, D., Wang, R., & Reichardt, L. F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-05.2005 · Cited by 177
VEGF blocking therapy in the treatment of cancer
Glade-Bender, J., Kandel, J. J., & Yamashiro, D. J. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.263 · Cited by 171
The synergistic activity of αvβ3 integrin and pdgf receptor increases cell migration
Woodard, A. S., García-Cardeña, G., Leong, M., Madri, J. A., Sessa, W. C., & Languino, L. R. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.4.469 · Cited by 165
Pampori, N. A., Hato, T., Stupack, D. G., Aïdoudi, S., Cheresh, D. A., Nemerow, G. R., & Shattil, S. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21609 · Cited by 162
Molecular Pathway for Cancer Metastasis to Bone
De, S., Chen, J., Narizhneva, N. V., Heston, W., Brainard, J., Sage, E. H., & Byzova, T. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304494200 · Cited by 162
Self-citationRahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M., & Wijelath, E. S. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-8 · Cited by 161
Vascular Integrins in Tumor Angiogenesis: Mediators and Therapeutic Targets
Alghisi, G. C., & Rüegg, C. (2006) · Endothelium · doi:10.1080/10623320600698037 · Cited by 159
αvβ3 integrin and angiogenesis: a moody integrin in a changing environment
Hodivala‐Dilke, K. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.06.007 · Cited by 154
Graells, J., Vinyals, A., Figueras, A., Llorens, A., Moreno, A., Marcoval, J., Gonzalez, F. J., & Fabra, À. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23460.x · Cited by 152
Boeuf, F. L., Houle, F., & Huot, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405493200 · Cited by 151
Role of alpha v integrins during angiogenesis.
Eliceiri, B. P., & Cheresh, D. A. (2000) · PubMed · Cited by 146
Regulation of angiogenesis: apoptotic cues from the ECM
Cheresh, D. A., & Stupack, D. G. (2008) · Oncogene · doi:10.1038/onc.2008.304 · Cited by 141
Wang, J. F., Zhang, X.-F., & Groopman, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101370200 · Cited by 140
Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response
Qu, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00322-1 · Cited by 139
Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial Permeability
Becker, P. M., Waltenberger, J. L., Yachechko, R., Mirzapoiazova, T., Sham, J. S. K., Lee, C. G., Elias, J. A., & Verin, A. D. (2005) · Circulation Research · doi:10.1161/01.res.0000171756.13554.49 · Cited by 137
Lowell, C., Niwa, M., Soriano, P. M., & Varmus, H. E. (1996) · Blood · doi:10.1182/blood.v87.5.1780.1780 · Cited by 135
Vlahakis, N. E., Young, B. A., Atakilit, A., Hawkridge, A. E., Issaka, R. B., Boudreau, N. J., & Sheppard, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609323200 · Cited by 133
Integrin and Growth Factor Receptor Alliance in Angiogenesis
Somanath, P. R., Ciocea, A., & Byzova, T. V. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9040-5 · Cited by 128
Self-citationMasson‐Gadais, B., Houle, F., Laferrière, J., & Huot, J. (2003) · Cell Stress and Chaperones · Cited by 123
Laramée, M., Chabot, C., Cloutier, M., Stenne, R., Holgado-Madruga, M., Wong, A. J., & Royal, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m611327200 · Cited by 119
Trusolino, L., Serini, G., Cecchini, G., Besati, C., Ambesi‐Impiombato, F. S., Marchisio, P. C., & Filippi, R. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.4.1145 · Cited by 116
Byzova, T. V., Goldman, C. K., Jankau, J., Chen, J., Cabrera, G., Achen, M. G., Stacker, S. A., Carnevale, K. A., Siemionow, M., Deitcher, S. R., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4434 · Cited by 113
Self-citationYamaoka‐Tojo, M., Tojo, T., Kim, H. W., Hilenski, L. L., Patrushev, N. A., Zhang, L., Fukai, T., & Ushio‐Fukai, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000231524.14873.e7 · Cited by 110
Mould, A. P., Garratt, A. N., Puzon-McLaughlin, W., Takada, Y., & Humphries, M. J. (1998) · Biochemical Journal · doi:10.1042/bj3310821 · Cited by 107
Akt1 Signaling Regulates Integrin Activation, Matrix Recognition, and Fibronectin Assembly
Somanath, P. R., Kandel, E., Hay, N., & Byzova, T. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700241200 · Cited by 106
Self-citationColuccia, A. M. L., Cirulli, T., Neri, P. E., Mangieri, D., Colanardi, M. C., Gnoni, A., Renzo, N. D., Dammacco, F., Tassone, P., Ribatti, D., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116590 · Cited by 101
Peptide‐based Molecules in Angiogenesis
D’Andrea, L. D., Gatto, A. D., Pedone, C., & Benedetti, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00356.x · Cited by 101
VE-cadherin Links tRNA Synthetase Cytokine to Anti-angiogenic Function
Tzima, E., Reader, J. S., Irani-Tehrani, M., Ewalt, K. L., Schwartz, M. A., & SCHIMMEL, P. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400431200 · Cited by 101
Integrin tyrosine phosphorylation in platelet signaling
Phillips, D. R., Prasad, K. S. S., Manganello, J. M., Bao, M., & Nannizzi‐Alaimo, L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00250-7 · Cited by 100
Maile, L. A., & Clemmons, D. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109258200 · Cited by 99
Src Family Nonreceptor Tyrosine Kinases as Molecular Targets for Cancer Therapy
Johnson, F. M., & Gallick, G. E. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007784111278 · Cited by 97
Ukropec, J. A., Hollinger, M. K., & Woolkalís, M. J. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5453 · Cited by 94
New Role for the Protein Tyrosine Phosphatase DEP-1 in Akt Activation and Endothelial Cell Survival
Chabot, C., Spring, K., Gratton, J., Elchebly, M., & Royal, I. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01374-08 · Cited by 83
The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling
Mattila, E., Auvinen, K., Salmi, M., & Ivaska, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.031898 · Cited by 83
Molecular Mechanisms Underlying the Proangiogenic Effect of Factor XIII
Dardik, R., Loscalzo, J., Eskaraev, R., & Inbal, A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154137.21230.80 · Cited by 83
Integrin affinity modulation in angiogenesis
Mahabeleshwar, G. H., Chen, J., Feng, W., Somanath, P. R., Razorenova, O. V., & Byzova, T. V. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5234 · Cited by 81
Self-citationCooperation between VEGF and β3 integrin during cardiac vascular development
Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., & Cheresh, D. A. (2006) · Blood · doi:10.1182/blood-2005-10-038893 · Cited by 77
Signalling by the p60 family of protein—tyrosine kinases
Kefalas, P., Brown, T. R. P., & Brickell, P. M. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00024-j · Cited by 76
Monoclonal antibodies as probes of integrin priming and activation
Humphries, M. J. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320407 · Cited by 69
Mitola, S. M. F., Brenchio, B., Piccinini, M., Tertoolen, L. G. J., Zammataro, L. A., Breier, G., RINAUDO, M. T., den Hertog, J., Arese, M., & Bussolino, F. (2005) · Circulation Research · doi:10.1161/01.res.0000199355.32422.7b · Cited by 69
Ling, Y., Maile, L. A., & Clemmons, D. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0143 · Cited by 67
Tyrosine 1213 of Flt-1 Is a Major Binding Site of Nck and SHP-2
Igarashi, K., Isohara, T., Kato, T., Shigeta, K., Yamano, T., & Uno, I. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8578 · Cited by 64
Yan, L., Maile, L. A., Lieskovská, J., Badley-Clarke, J., & Clemmons, D. R. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0918 · Cited by 63
Su, X., Mi, J., Yan, J., Flevaris, P., Lu, Y., Liu, H., Ruan, Z., Wang, X., Kieffer, N., Chen, S., et al. (2008) · Blood · doi:10.1182/blood-2007-09-110437 · Cited by 60
Basson, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2992 · Cited by 53
The angiogenic response is dictated by β3 integrin on bone marrow–derived cells
Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802179 · Cited by 52
Self-citationFolgiero, V., Avetrani, P., Bon, G., Carlo, S. E. D., Fabi, A., Nisticò, C., Vici, P., Melucci, E., Buglioni, S., Perracchio, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001592 · Cited by 51
Lieskovská, J., Ling, Y., Badley-Clarke, J., & Clemmons, D. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602866200 · Cited by 51
Yan, L., Maile, L. A., Badley-Clarke, J., & Clemmons, D. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411035200 · Cited by 49
Antiangiogenic Agents in Cancer Therapy
Lenz, H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-184-0 · Cited by 49
Clemmons, D. R., Maile, L. A., Ling, Y., Yarber, J., & Busby, W. H. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.01.004 · Cited by 48
A review: Integrin αvβ3-targeted molecular imaging and therapy in angiogenesis
Lim, E., Danthi, N. S., Bednarski, M. D., et al. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2005.03.008 · Cited by 45
Ligand-dependent Activation of Integrin αvβ3
Butler, B., Williams, M. P., & Blystone, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206997200 · Cited by 44
Lakhe-Reddy, S., Khan, S., Konieczkowski, M., Jarad, G., Wu, K. L., Reichardt, L. F., Takai, Y., Bruggeman, L. A., Wang, B., Sedor, J. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601110200 · Cited by 43
Insulin-like Growth Factor-I Receptor Mediates the Prosurvival Effect of Fibronectin
Edderkaoui, M., Hong, P., Lee, J. K., Pandol, S. J., & Gukovskaya, A. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702836200 · Cited by 40
Chapter 7 Molecular Imaging of Tumor Vasculature
Cai, W., Gambhir, S. S., & Chen, X. S. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03007-3 · Cited by 39
Chandhoke, S. K., Williams, M., Schaefer, E., Zorn, L., & Blystone, S. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00987 · Cited by 33
Kwon, M., Yan, L., Maile, L. A., Badley-Clarke, J., & Clemmons, D. R. (2005) · Endocrinology · doi:10.1210/en.2005-1115 · Cited by 28
Herouy, Y., Mellios, P., Bandemir, E., Stetter, C., Dichmann, S., Idzko, M., Hofmann, C., Vanscheidt, W., Schöpf, E., & Norgauer, J. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.6.5.515 · Cited by 28
Cancer angiogenesis: Targeting the heel of Achilles
Dass, C. R., & Choong, P. (2008) · Journal of drug targeting · doi:10.1080/10611860802088523 · Cited by 19
Napoleone Ferrara and the Saga of Vascular Endothelial Growth Factor
Ribatti, D. (2008) · Endothelium · doi:10.1080/10623320802092377 · Cited by 14
Cited by
Targeting integrin pathways: mechanisms and advances in therapy
Pang, X., He, X., Qiu, Z., Zhang, H., Xie, R., Liu, Z., Gu, Y., Zhao, N., Xiang, Q., & Cui, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01259-6 · Cited by 1,275
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker-Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 534
Endothelial von Willebrand factor regulates angiogenesis
Starke, R. D., Ferraro, F., Paschalaki, K. E., Dryden, N. H., McKinnon, T. A. J., Sutton, R. E., Payne, E. M., Haskard, D. O., Hughes, A. D., Cutler, D. F., et al. (2011) · Blood · doi:10.1182/blood-2010-01-264507 · Cited by 512
Integrins as therapeutic targets
Goodman, S. L., & Picard, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.002 · Cited by 376
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Cui, X., Morales, R.-T. T., Qian, W., Wang, H., Gagner, J.-P., Dolgalev, I., Placantonakis, D., Zagzag, D., Cimmino, L., Snuderl, M., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.053 · Cited by 267
Metadata
- Authors
- Somanath, P. R., Malinin, N. L., & Byzova, T. V.
- Venue
- Angiogenesis
- Published
- 2009-03-08
- Volume
- 12
- Issue
- 2
- Pages
- 177-185
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- OpenAlex
- W1967348819
- Cited by
- 254
- References
- 102
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.